Jake Olivier, Ph.D. PEER-REVIEWED JOURNAL ARTICLES
* Supervision of student or post-doc in underline
1. Heinzelmann-Schwarz VA, Nixdorf S, Valadan M, Diczbalis M, Olivier J, Otton G,
Fedier A, Hacker NF & Scurry JP. A clinicopathological review of 33 patients with
vulvar melanoma identifies c-KIT as a prognostic marker. International Journal of Molecular Medicine, accepted 21 January 2014.
2. Olivier J. The apparent ineffectiveness of bicycle helmets: A case of selective citation
(letter). Gaceta Sanitaria, accepted 10 September 2013.
3. McDaniel OG, Rigney D, Olivier J, McDaniel KY, Brock M, Redmond P & Porter P.
Trauma Induced Inflammation, Sepsis and Ageing. Ageing International, accepted 1
4. Bell ML, Teixeira-Pinto A, McKenzie J & Olivier J. A myriad of methods: calculated
sample size for two proportions was dependent on the choice of sample size formula
and software. Journal of Clinical Epidemiology, accepted 21 October 2013.
5. Wang J, Olivier J & Grzebieta R. (2014) Response to ‘Evaluation of New Zealand’s
bicycle helmet law’ (letter). New Zealand Medical Journal, 127(1389): 106-108.
6. Raju S, Davis M, Kirk O & Olivier J. (2014) Hemodynamics of 'Critical' Venous
Stenosis and Stent Treatment. Journal of Vascular Surgery: Venous and Lymphatic
7. Norberg MM, Olivier J, Schmidt NB & Zvolensky MJ. (2014) Cannabis Use among
Treatment-Seeking Smokers: Motives and the Moderating Effects of Anxiety
Sensitivity. American Journal on Addictions, 23(1): 7-14.
8. Mooren L, Grzebieta R, Williamson A, Olivier J & Friswell R. (2014) Safety
Management for Heavy Vehicle Transport: A Review of the Literature. Safety
9. Olivier J & Walter SR. (2013) Bicycle helmet wearing is not associated with close
overtaking: A reanalysis of Walker (2007). PLOS ONE, 8(9): e75424. Erratum in: PLOS
10. Diffner E, Beck D, Gudgin E, Thoms JAI, Knezevic K, Pridans C, Foster S, Goode D, Lim
WK, Boelen L, Metzeler KH, Micklem G, Bohlander SK, Buske C, Burnett A,
Ottersbach K, Vassiliou GS, Olivier J, Wong JW, Göttgens B, Huntly BJ & Pimanda JE.
(2013) Activity of a heptad of transcription factors is associated with stem cel
programs and clinical outcome in acute myeloid leukaemia. Blood, 121(12): 2289-
11. Olivier J & Bel ML. (2013) Effect sizes for 2×2 contingency tables. PLOS ONE, 8(3):
12. Olivier J & Bel ML. (2013) The Importance of Statistics in Cancer Research. World Journal of Cancer Research, 1: 78-81.
13. Bell ML, Olivier J & King MT. (2013) Scientific rigour in psycho-oncology trials: why
and how to avoid common statistical errors. Psycho-oncology, 22: 499-505.
14. Bambach MR, Mitchell RJ, Grzebieta RH & Olivier J. (2013) The effectiveness of
helmets in bicycle collisions with motor vehicles: A case-control study. Accident Analysis and Prevention, 53: 78-88.
15. Walter SR, Olivier J, Churches T & Grzebieta R. (2013) The impact of compulsory
cycle helmet legislation on cyclist head injuries in New South Wales, Australia: A
response. Accident Analysis and Prevention, 52: 204-209.
16. McDonald KL, Rapkins RW, Olivier J, Zhao JL, Nozue K, Lu D, Tiwari S, Kuroiwa-
Trzmielina J, Brewer J, Wheeler HR & Hitchins MP. (2013) The T genotype of the
MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is
associated with promoter methylation and longer survival in glioblastoma patients.
European Journal of Cancer, 49: 360-368.
17. Olivier J, Walter SR & Grzebieta RH. (2013) Long term bicycle related head injury
trends for New South Wales, Australia following mandatory helmet legislation.
Accident Analysis and Prevention, 50: 1128-1134.
18. Walker R, Hunt YM, Olivier J, Grothe KB, Dubbert PM, Burke RS & Cushman WC.
(2012) Descriptive Characteristics and Cluster Analysis of Male Veteran Hazardous
Drinkers in an Alcohol Moderation Intervention. The American Journal on Addictions,
19. Olivier J, Churches T, Walter S, McIntosh A & Grzebieta R. (2012) Response to Rissel
and Wen, “The possible effect on frequency of cycling if mandatory bicycle helmet
legislation was repealed in Sydney, Australia: a cross sectional survey” (letter).
Health Promotion Journal of Australia, 23(1): 76.
20. Poulos RG, Chong SSS, Olivier J & Jalaludin B. (2012) Geospatial analyses to prioritize
public health interventions: a case study of pedestrian and pedal cycle injuries in
New South Wales, Australia. International Journal of Public Health, 57(3): 467-475.
21. Stavrou E, Buckley N, Olivier J & Pearson SA. (2012) Discontinuation of statin
therapy in older people: does a cancer diagnosis make a difference? An
observational cohort study using data linkage. BMJ Open, 2:e000880.
22. Raju S, Sanford P, Herman S & Olivier J. (2012) Postural and Ambulatory Changes in
Regional Flow and Skin Perfusion. European Journal of Vascular and Endovascular
23. Jacob F, Ukegijni K, Nixdorf S, Ford CE, Olivier J, Caduff R, Scurry JP, Guertler R,
Hornung D, Mueller R, Fink DA, Hacker NR & Heinzelmann-Schwarz VA. (2012) Loss
of secreted frizzled-related protein 4 correlates with an aggressive phenotype and
predicts poor outcome in ovarian cancer patients. PLOS ONE 7(2): e31885.
24. Mitchell R, Williamson A & Olivier J. (2011) Population-risk and person-time risk
drowning rates-The Authors response (letter). Injury Prevention, 17(5): 359-360.
25. Langton JM, Drew A, Mellish L, Olivier J, Ward RL & Pearson SA. (2011) The quality of
web-based oncology guidelines and protocols: how do international sites stack up?
British Journal of Cancer, 105(8): 1166-1172.
26. Bambach MR, Grzebieta RH, Olivier J & McIntosh AS. (2011) Fatality Risk for
Motorcyclists in Fixed Object Collisions. Journal of Transportation Safety and
27. Walter SR, Olivier J, Churches T & Grzebieta R. (2011) The impact of compulsory
cycle helmet legislation on cyclist head injuries in New South Wales, Australia.
Accident Analysis and Prevention, 43(6): 2064-2071.
28. Neglén P, Oglesbee M, Olivier J & Raju S. (2011) Stenting of Chronically Obstructed
IVC filters. Journal of Vascular Surgery, 54(1): 153-161.
29. Norberg MM, Olivier J, Alperstein DM, Zvolensky MJ & Norton AR. (2011) Adverse
Consequences of Student Drinking: The Role of Sex, Social Anxiety, and Drinking
Motives. Addictive Behaviors, 36(8): 821-828.
30. Curtis K, Olivier J, Mitchel R, Cook A, Rankin T, Rana A, Watson W & Nau T. (2011)
Evaluation of a Tiered Trauma System in a Level 1 Trauma Centre. Injury, 42(1): 57-
31. Norberg MM, Norton AR, Olivier J & Zvolensky MJ. (2010) Social Anxiety, Reasons
for Drinking and College Students. Behavior Therapy, 41(4): 555-566.
32. Doukas G, Olivier J, Poulos R & Grzebieta R. (2010) Exploring differential trends in
severe and fatal child pedestrian injury in New South Wales, Australia (1997-2006).
Accident Analysis and Prevention, 42(6): 1705-1711.
33. Harvey LA, Poulos RG, Finch CF, Olivier J & Harvey JG. (2010) Hospitalised hot tap
water scald patients fol owing the introduction of regulations in NSW, Australia: who
have we missed? Burns, 36(6): 912-919.
34. Mitchell R, Williamson A & Olivier J. (2010) Estimates of drowning morbidity and
mortality adjusted for exposure to risk. Injury Prevention, 16(4): 261-266.
35. Olivier J & Norberg MM. (2010) Positively skewed data: Revisiting the Box-Cox
Power Transformation. International Journal of Psychological Research, 3(1): 69-78.
36. Neglén P, Darcey RL, Olivier J & Raju S. (2010) Bilateral Stenting at the Ilio-caval
Confluence. Journal of Vascular Surgery, 51(6): 1457-1466.
37. Fulop T, Olivier J, Meador RS, Hall J, Islam N, Mena L, Henderson H & Schmidt DW.
(2010) Screening for Chronic Kidney Disease in the Ambulatory HIV Population.
Clinical Nephrology, 73(3): 190-196.
38. Chong S, Poulos R, Olivier J, Watson W & Grzebieta R. (2010) Relative injury severity
among vulnerable non-motorised road users: comparative analysis of injury arising
from bicycle-motor vehicle and bicycle-pedestrian collisions. Accident Analysis and
39. Norberg MM, Norton AR & Olivier J. (2009) Refining Measurement in the Study of
Social Anxiety and Student Drinking: Who You Are and Why You Drink Determines
Your Outcomes. Psychology of Addictive Behaviors, 23(4): 586-597.
40. Mitchell R, McClure R, Olivier J & Watson W. (2009) Rational allocation of Australia’s
research dol ars: Does the distribution of NHMRC funding by National Health Priority
Area reflect actual disease burden? Medical Journal of Australia, 191(11-12): 648-
41. Ly TH, de Shazo RD, Olivier J, Stringer SP, Daley W & Stodard CM. (2009) Diagnostic
Criteria for Atrophic Rhinosinusitis. American Journal of Medicine, 122(8): 747-753.
42. Burton MJ, Olivier J & Mena L. (2009) Characteristics of Hepatitis C Virus Coinfection
in a Human Immunodeficiency Virus-Infected Population With Lower Reported Rates
of Injection Drug Use. The American Journal of the Medical Sciences, 338(1): 54-56.
43. Zhou X, Olivier J & McDaniel DO. (2009) Impact of Socioeconomic Disparities and
Education on Trauma-induced Clinical Complications. Public Administration and
44. Cleary JD, Pearson M, Olivier J & Chapman SW. (2008) Association Between
Histoplasma Exposure and Stroke. Journal of Stroke and Cerebrovascular Diseases,
45. Kendzor DE, Dubbert PM, Olivier J, Businelle MS, Grothe KB & the PATHS
Investigators. (2008) The Influence of Physical Activity on Alcohol Consumption
among Heavy Drinkers Participating in an Alcohol Treatment Intervention. Addictive
46. Duchesne JC, Schmieg R, Islam S, Olivier J & McSwain N. (2008) Selective
Nonoperative Management of Low-Grade Blunt Pancreatic Injury: Are We There
Yet? The Journal of Trauma, 65(1): 49-53.
47. Grothe KB, Bodenlos JS, Whitehead D, Olivier J & Brantley PJ. (2008) The
Psychosocial Vulnerability Model of Hostility as a Predictor of Coronary Heart
Disease in Low-Income African Americans. Journal of Clinical Psychology in Medical
48. Brar H, Olivier J, Lebrun C, Gabbard W, Fulop T & Schmidt D. (2008) Predictors of
Mortality in a Cohort of Intensive Care Unit Patients with Acute Renal Failure
Receiving Continuous Renal Replacement Therapy. The American Journal of the Medical Sciences, 335(5): 342-347.
49. Olivier J, Johnson WD & Marshal GD. (2008) The Logarithmic Transformation and
the Geometric Mean in Reporting Experimental IgE Results: what are they and when
and why to use them? Annals of Al ergy, Asthma & Immunology, 100(4): 333-337.
Erratum in: Annals of Al ergy, Asthma & Immunology, 100(6): 625-626.
50. Duchesne JC, Kyle A, Simmons J, Islam S, Schmieg RE, Olivier J & McSwain NE. (2008)
Impact of Telemedicine Upon Rural Trauma Care. The Journal of Trauma, 64(1): 92-
51. Olivier J & May WL. (2007) A Discussion of Binomial Interval Estimators on the
Boundary. Journal of the Mississippi Academy of Sciences, 52(2,3): 178-183.
52. Neglén P, Hollis KC, Olivier J & Raju S. (2007) Stenting of the Venous Outflow in
Chronic Venous Disease: Long-term Stent-related Outcome, Clinical and
Hemodynamic Result. Journal of Vascular Surgery, 46(5): 979-990.
53. Payne JA, Snyder DC, Olivier J & Salameh JR. (2007) Total Abdominal Colectomy:
Patient Satisfaction and Outcomes. The American Surgeon, 73(7): 709-711.
54. Roy SR, Sigmon JR, Olivier J, Moffitt JE, Brown DA & Marshall GD. (2007) Increased
Frequency of Large Local Reactions Among Systemic Reactors During Subcutaneous
Allergen Immunotherapy. Annals of Allergy, Asthma & Immunology, 99(1): 82-86.
55. Adcock KG, Ostrenga J, Hogan SM & Olivier J. (2007) Evaluating Comprehension by
Children of Clinical Research Assent Documents. ACRP Monitor, 21(2): 61-64.
56. Adcock KG, Kyle PB, Deaton JS, Olivier J & Hogan SM. (2007) Pharmacokinetics of
Intranasal and Intratracheal Pentoxifylline in Rabbits. Pharmacotherapy, 27(2): 200-
57. Sample RC, Bryan L, Long S, Majji S, Hoskins G, Sinning A, Olivier J & Chinchar VG.
(2007) Inhibition of Iridovirus Protein Synthesis and Virus Replication by Antisense
Morpholino Oligonucleotides Targeted to the Major Capsid Protein, the 18 kDa
Immediate-Early protein, and a Viral Homolog of RNA Polymerase II. Virology,
58. Sherer M, Stouter J, Hart T, Nakase-Richardson R, Olivier J, Manning E &Yablon SA.
(2006) Computed Tomography Findings and Early Cognitive Outcome after
Traumatic Brain Injury. Brain Injury, 20(10): 997-1005.
59. Boyd KB, Olivier J & Salemeh JR. (2006) Surgical Residents’ Perception of Simulation
Training. The American Surgeon, 72(6): 521-524.
60. Stokic DS, Yablon SA, Hayes A, Vesovic-Potic V & Olivier J. (2006) Dose-Response
Relationship Between H-reflex and Continuous Intrathecal Baclofen Administration
for Management of Spasticity. Clinical Neurophysiology, 117(6): 1283-1289.
61. Olivier J & May W. (2006) Weighted Confidence Interval Construction for Binomial
Parameters. Statistical Methods in Medical Research, 15(1): 37-46.
62. Leis AA, Stokic DS & Olivier J. (2005) Statins and Peripheral Neuropathy: Setting the
Record Straight. Muscle and Nerve, 32(4): 428-430.
63. Adah F, Benghuzzi H, Tucci M, Russell G, Tsao A, Olivier J & England B. (2005)
Evaluation of the Male Reproductive Organs After Treatment with Continuous
Sustained Delivery of Statin for Fracture Healing. Biomedical Sciences
64. Neglén P, Egger J, Olivier J & Raju S. (2004) Hemodynamic and Clinical Impact of
Ultra-Sound Derived Venous Reflux Parameters. Journal of Vascular Surgery, 40(2):
CONFERENCE PROCEEDINGS
65. *Olivier J, Grzebieta R, Wang JJJ & Walter, S. (2013) Statistical Errors in Anti-Helmet
Arguments. Proceedings of the Australasian Col ege of Road Safety Conference.
66. *Wang JJJ, Grzebieta R, Walter S & Olivier J. (2013) An evaluation of the methods
used to assess the effectiveness of mandatory bicycle helmet legislation in New
Zealand. Proceedings of the Australasian Col ege of Road Safety Conference.
67. *Olivier J, Wang JJJ, Walter S & Grzebieta R. (2013) On the use of empirical Bayes for
comparative interrupted time series with an application to mandatory helmet
legislation. Proceedings of the Australasian Road Safety, Research, Policing and
68. *Wang JJJ, Walter S, Grzebieta R & Olivier J. (2013) A Comparison of Statistical
Methods in Interrupted Time Series Analysis to Estimate an Intervention Effect.
Proceedings of the Australasian Road Safety, Research, Policing and Education
69. *Williamson A, Friswell R, Grzebieta R & Olivier J. (2013) What do we tel drivers
about fatigue management. Contemporary Ergonomics and Human Factors 2013,
70. *Mooren L, Grzebieta R, Williamson A & Olivier J. (2012) Comparing heavy vehicle
safety management in Australia and the United States. Proceedings of the Australasian Col ege of Road Safety National Conference
71. Olivier J & Descallar J. (2011) Statistical power of relative risk in Poisson regression:
How important is exposure data? 2011 JSM Proceedings, Statistics in Epidemiology
Section. Alexandria, VA: American Statistical Association, 1017-1023.
72. *Falster MO, Olivier J, Chong S, Grzebieta R & Watson W. (2009) Trends in severe
pedestrian injuries among older people in NSW. Proceedings of the Australasian Road Safety Research, Policing and Education Conference, 392-399.
73. Olivier J & Johnson WD. (2005) Logistic Regression Analysis Using Maple. Proceedings of Maple Conference 2005, 63-69.
74. *Faruque F, Carithers T, Wilson K, Williams W, Li H, May W & Olivier J. (2005)
Evaluation of a Method of Estimating Agricultural Chemical Use. WIT Transactions on Ecology and the Environment, 85: 409-418.
SCIENTIFIC ARTICLES IN POPULAR MEDIA
75. Olivier J, Walter S & Grzebieta. (2012) Bike helmet critics not using their heads. The National Times, published 3 October 2012.
76. Olivier J, Hayen A, Walter S, Churches T & Grzebieta R. (2012) Cycling rates are
actually up, despite those creaky knees. ABC Environment, published 18 July 2012.
77. Olivier J. (2012) Don't blame mandatory helmets for cyclist deaths in New Zealand. The Conversation, published 16 February 2012.
78. Olivier J. (2011) Putting a lid on the debate: mandatory helmet laws reduce head
injuries. The Conversation, published 23 June 2011.
TECHNICAL REPORTS
79. Norberg MM, Battisti RA, Copeland J, Hermens DF, Olivier J & Hickie IB. (2011) The
Cannabis Check-Up+: A Brief Intervention For Help-Seeking Young Adult And
Adolescent Cannabis Users With Psychiatric Comorbidity. Prepared for the
Australian Government Department of Health and Ageing.
80. Hatfield J, Friswell R, Olivier J & Grzebieta R. (2009) Pilot study of the effect of the
Australian Youth and Road Trauma Forum on year 11 high school students. Prepared
for Motor Accidents Authority of New South Wales.
INFORMACION PARA PRESCRIBIR AMPLIA Nombre Comercial: ANUAR ASF® Nombre Genérico: CABERGOLINA Forma Farmacéutica y Formulación: Comprimidos. Cabergolina. 0.5 mg Excipiente cbp…………………………………………………. 1 comprimido Indicaciones Terapéuticas: Inhibidor de la secreción de prolactina (PRL), Agonista dopaminérgico. ANUAR ASF�
Stabilized Autologous Fibrin-Chondrocyte Constructs for Martin Fussenegger, MD,* Johann Meinhart, PhD,† Walter Höbling, MD,‡ Werner Kullich, PhD,§ Siegfried Funk, MD,¶ and Gu¨nther Bernatzky, PhD method, because it is able to overcome many of the problems Abstract: Stabilization of fibrin-chondrocyte constructs with fi- brinolytical inhibitors has been shown to be a feasible metho